Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nuvamid Logo
Nuvamid Growth Score
83
CB Rank
919790
Heat Score
48
Nuvamid is a pharmaceutical company that develops and manufactures novel therapeutics for immune disorders.
Founded
obfuscation
Private Lausanne, Vaud, Switzerland11-50 nuvamid.com
Health Care
Manufacturing
Pharmaceutical
Overview

Nuvamid
Growth Score
83
Heat Score
48

Growth Score83
-4 pts
in past quarter
Heat Score 48
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nuvamid

CB Rank
919790
Nuvamid is a pharmaceutical company that develops and manufactures novel therapeutics for immune disorders.
Founded
obfuscation
Private Lausanne, Vaud, Switzerland11-50 nuvamid.com
Health Care
Manufacturing
Pharmaceutical

Details

Legal Name Nuvamid
Operating Status Active
Company Type For Profit
Phone Number +41 213115352
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Novel Therapeutics for Immune Disorders
Development and manufacturing of new treatments targeting immune system disorders, focusing on rare and orphan diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

IT Spend

$78.7KThis year, Nuvamid is projected to spend $78.7K on IT, according to Aberdeen.

Active Website Tech Count

6Nuvamid is actively using 6 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

29The intellectual property of Nuvamid includes 28 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Nuvamid has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Nuvamid's headquarters? Nuvamid is located in Lausanne, Vaud, Switzerland.Who are Nuvamid's competitors? Alternatives and possible competitors to Nuvamid may include Amgen, Takeda, and  argenx.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|